[1] Kocao,Uns,Turkh,et al.The factors predicting biochemical recurrence in patients with radical prostatectomy[J].Arch Ital Urol Androl,2016,87(4):270-275. [2] 那彦群,叶章群,孙光.中国泌尿外科疾病诊断治疗指南手册[M].北京:人民卫生出版社,2011:55. [3] 周刚,彭境罗,刘幸生,等.f/tPSA与PSAD对tPSA灰区且直肠指检阴性前列腺癌诊断价值的 Meta分析[J].循证医学,2015,3(1) :952. [4] 蒲永昌,高斌.经直肠前列腺18针穿刺活检与10针活检在PSA(4~10μg /L) 患者中诊断前列腺癌的对比性研究[J].吉林医学,2015,3(9) :1005. [5] Greene KL,Albertsen PC,Babaian RJ,et al.Prostate specific antigen best practice statement:2009 update[J].J Urol,2013,189(1 Suppl):S2-S11. [6] 顾炜,徐耀庭,谢敏.PSA、FPSA/TPSA和PSAD在前列腺癌诊断中的价值[J].老年医学与保健,2010,16(2) :117. [7] 陈锐,谢立平,周利群,等.中国前列腺癌联盟成员医院前列腺穿刺活检现状的调查报告[J].中华泌尿外科杂志,2015,36(5):342-345. [8] Andriole GL,Crawford ED,Grubb RL 3rd,et al.Mortality results from a randomized prostate-cancer screening trial[J].N Engl J Med,2009,360(17):1310. |